Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0000950170-24-141597

Chief Financial Officer sold 4,865 shares at an average $4.42 ($21,491)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Catinazzo Thomas · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-12-27 Sale : show line 1 in the form 10b5-1 −299 $4.38 $1,310 303,792 D
2024-12-27 Sale : show line 2 in the form 10b5-1 −4,566 $4.42 $20,182 299,226 D
Open-market sales · 4,865 sh · avg $4.42 · $21,491
Loading xslF345X05/ownership.xml…